The physician begins the Minnesota Anti-Lympocyte Globulin Program. Transplant patients received ALG to prevent their bodies from rejecting transplant tissue after an operation. Researchers derived ...
Reports Q4 revenue $629k, consensus $433.33k. “2024 was a pivotal year for the company, paving the way for the future of Aligos,” stated ...
Hosted on MSN14d
Alamo (NYSE:ALG) Misses Q4 Revenue EstimatesSpecialized equipment manufacturer for infrastructure and vegetation management Alamo Group (NYSE:ALG) in Q4 CY2024, with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback